Cyalume Technologies (CYLU) 10-Q 18 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 10, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Registrant Name	Cyalume Technologies Holdings, Inc.
Entity Central Index Key	1,335,293
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	CYLU
Entity Common Stock, Shares Outstanding		22,347,549

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash	$ 1,151	$ 2,753
Accounts receivable, net of allowance for doubtful accounts of $6 and $8, respectively	5,003	3,379
Inventories, net	8,225	8,384
Income taxes refundable	169	187
Prepaid expenses and other current assets	1,444	1,078
Total current assets	15,992	15,781
Property, plant and equipment, net	7,020	7,036
Goodwill	7,992	7,992
Other intangible assets, net	4,791	4,951
Total assets	35,795	35,760
Current liabilities:
Line of credit	1,000	0
Current portion of notes payable	1,288	1,066
Accounts payable	1,511	1,643
Accrued expenses	2,587	4,236
Deferred revenue and deferred rent	31	37
Income taxes payable	157	82
Warrants liability	47	72
Total current liabilities	6,621	7,136
Notes payable, net of current portion	11,373	11,752
Deferred income taxes	631	626
Asset retirement obligation	228	226
Other noncurrent liabilities	90	88
Total liabilities	18,943	19,828
Commitments and contingencies (Note 12)
Stockholders’ equity:
Series B convertible preferred stock, $0.001 par value; 1,000,000 shares authorized; 1,000 shares issued and outstanding	1,401	1,401
Common stock, $0.001 par value; 150,000,000 shares authorized; 22,347,549 and 21,400,244 shares issued and outstanding, respectively	22	21
Additional paid-in capital	101,936	102,031
Accumulated deficit	(96,903)	(97,618)
Accumulated other comprehensive loss	(1,055)	(1,103)
Total stockholders’ equity	5,401	4,732
Total liabilities and stockholders' equity	35,795	35,760
Series C Preferred Stock [Member]
Temporary Equity
Temporary Equity	2,744	2,665
Series D Convertible Preferred Stock [Member]
Temporary Equity
Temporary Equity	2,751	2,751
Series A Convertible Preferred Stock [Member]
Temporary Equity
Temporary Equity	$ 5,956	$ 5,784

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Accounts receivable, allowance for doubtful accounts	$ 6	$ 8
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	22,347,549	21,400,244
Common stock, shares outstanding	22,347,549	21,400,244
Series A Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	123,097	123,097
Preferred stock, shares outstanding	123,097	123,097
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series B convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series D Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	10	10
Preferred stock, shares outstanding	10	10

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues	$ 11,097	$ 9,242
Cost of revenues	5,758	4,512
Gross profit	5,339	4,730
Other expenses:
Sales and marketing	959	593
General and administrative	2,039	2,149
Research and development	483	391
Interest expense, net	642	729
Amortization of intangible assets	239	240
Change in fair value of warrant liability	38	(13)
Other expenses, net	4	26
Total other expenses, net	4,404	4,115
Income before income taxes	935	615
Provision for income taxes	220	136
Net income	715	479
Other comprehensive income, net of tax:
Foreign currency translation adjustments	48	118
Other comprehensive income	48	118
Comprehensive income	763	597
Net income	715	479
Net income available to common stockholders - basic	464	254
Series A convertible preferred stock dividends	172	154
changes in Fair Value Adjustment Of Warrants	0	(13)
Net income available to common stockholders - diluted	$ 636	$ 395
Income per common share:
Basic (in dollars per share)	$ 0.02	$ 0.01
Diluted (in dollars per share)	$ 0.01	$ 0
Weighted average shares used to compute net income per common share:
Basic (in shares)	22,084,684	21,400,244
Diluted (in shares)	115,442,536	104,237,394
Series A Convertible Preferred Stock [Member]
Other comprehensive income, net of tax:
Preferred stock dividends	$ (172)	$ (154)
Series C Preferred Stock [Member]
Other expenses:
Net income	0
Other comprehensive income, net of tax:
Other comprehensive income	0
Net income	0
Preferred stock dividends	$ (79)	$ (71)

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity - 3 months ended Mar. 31, 2017 - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Convertible Preferred Stock [Member]	Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Balance at Dec. 31, 2016	$ 4,732	$ 5,784	$ 2,665	$ 2,751	$ 1,401	$ 21	$ 102,031	$ (97,618)	$ (1,103)
Balance (in shares) at Dec. 31, 2016		123,097	1,000	10	1,000	21,400,244
Dividends accrued on Series A and Series C preferred stock	(251)	$ 172	$ 79	$ 0	$ 0	$ 0	(251)	0	0
Issuance of common shares upon warrant exercise	64	$ 0	$ 0		$ 0	$ 1	63	0	0
Issuance of common shares upon warrant exercise (in shares)		0	0	0	0	947,305
Share-based compensation	93	$ 0	$ 0	$ 0	$ 0	$ 0	93	0	0
Net income	715	0	0	0	0	0	0	715	0
Other comprehensive income	48	0	0	0	0	0	0	0	48
Balance at Mar. 31, 2017	$ 5,401	$ 5,956	$ 2,744	$ 2,751	$ 1,401	$ 22	$ 101,936	$ (96,903)	$ (1,055)
Balance (in shares) at Mar. 31, 2017		123,097	1,000	10	1,000	22,347,549

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income	$ 715	$ 479
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, plant and equipment	233	220
Amortization of intangible assets, debt issuance costs and debt discount	486	468
Share-based compensation expense	93	85
Change in fair value of warrant liability	38	(13)
Loss on disposal of property, plant and equipment	4	29
Other non-cash expenses	(1)	9
Changes in operating assets and liabilities:
Accounts receivable	(1,613)	577
Inventories	174	(31)
Prepaid expenses and other current assets	(280)	(251)
Restricted cash	(120)	153
Accounts payable and accrued liabilities	(1,784)	(1,549)
Deferred revenue and deferred rent	(6)	(52)
Income taxes payable	94	42
Net cash (used in) provided by operating activities	(1,967)	166
Cash flows from investing activities:
Purchases of long-lived assets	(207)	(127)
Payments for intangibles	(72)	(7)
Net cash used in investing activities	(279)	(134)
Cash flows from financing activities:
Repayment of long term notes payable	0	(378)
Repayments Of Monroe Term A Loan	(225)	0
Repayments Of Monroe Delayed Draw Loan	(37)	0
Borrowings on Monroe line of credit, net	1,000	0
Repayment of legal settlement promissory note	(107)	(107)
Net cash provided by (used in) financing activities	631	(485)
Effect of exchange rate changes on cash	13	9
Net decrease in cash	(1,602)	(444)
Cash, beginning of period	2,753	1,526
Cash, end of period	$ 1,151	$ 1,082

ORGANIZATION

ORGANIZATION	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	1. ORGANIZATION Cyalume Technologies Holdings, Inc. (the “Company”) was organized as a blank check company under the laws of the State of Delaware on July 19, 2005. At that time, the Company was named Vector Security Intersect Acquisition Corp. On December 19, 2008, the Company acquired Cyalume Technologies, Inc. (“CTI”) and changed the corporate name to the current name. CTI is a Delaware corporation formed on March 27, 1997 with headquarters located in Fort Lauderdale, Florida

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
BASIS OF PRESENTATION	2. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. All the adjustments which, in the opinion of management, are considered necessary for a fair presentation of the results of operations for the periods shown are of a normal recurring nature and have been reflected in the unaudited condensed consolidated financial statements. Results from operations for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2017. The consolidated balance sheet at December 31, 2016 has been derived from the audited consolidated financial statements at that date. The information included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto in our Annual Report on Form 10-K for the year ended December 31, 2016 filed on March 28, 2017. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. While the Company believes that such estimates are fair when considered in conjunction with the condensed consolidated financial position and results of operations taken as a whole, the actual amount of such estimates, when known, may vary from these estimates.

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	3 Months Ended
	Mar. 31, 2017
Business Combination, Description [Abstract]
DESCRIPTION OF BUSINESS	3. DESCRIPTION OF BUSINESS These consolidated financial statements and footnotes include the financial position and operations of Cyalume Technologies Holdings, Inc. (“Cyalume” or the “Company”), the parent company that is the sole shareholder of Cyalume Technologies, Inc. (“CTI”), of Cyalume Specialty Products, Inc. (“CSP”) and of CT SAS Holdings, Inc. (“CT SAS Holdings”). CTI is the sole shareholder of Cyalume Realty, Inc. (“CRI”). CT SAS Holdings is the sole shareholder of Cyalume Technologies, SAS (“CTSAS”). All significant intercompany accounts and transactions have been eliminated in consolidation. The Company’s primary focus is producing specialty chemicals and related products and sub-contract manufacturing of components for use in the pharmaceutical and medical products markets. The Company sells to the U.S. military and other militaries, and to major pharmaceutical and medical device companies throughout the world. CTI and CTSAS manufacture and sell chemiluminescent products and reflective and photoluminescent materials to military, ammunition, commercial and public safety markets. CTSAS is located in France and represents CTI in certain international markets, primarily Europe and the Middle East. CTI sells to customers in all other geographic markets. CTI’s and CTSAS’s business operations constitute the majority, based on revenues and assets, of the Company’s consolidated business operations. CSP manufactures on a subcontractor basis and sells specialty chemical products to the pharmaceutical, medical products, defense and other markets. CSP’s operations are located in Bound Brook, New Jersey. The Company’s business is managed and financial results are reported as one segment. The Company’s CEO, who is the Company’s chief operating decision maker, focuses on consolidated results to make strategic and tactical decisions. The Company’s one operating segment consists of three reporting units: Chemical Light (the operations of CTI, CTS and CTSAS), Specialty Products (the operations of CSP) and Other (the parent company Cyalume Technologies Holdings, Inc.).

PREPAID EXPENSES AND OTHER CURR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	3 Months Ended
	Mar. 31, 2017
Prepaid Expense and Other Assets, Current [Abstract]
PREPAID EXPENSES AND OTHER CURRENT ASSETS	4. PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets consist of the following (all amounts in thousands): March 31, December 31, 2017 2016 Prepaid expenses $ 897 $ 617 Debt issuance costs 422 456 Restricted cash (1) 120 0 Other current assets 5 5 $ 1,444 $ 1,078 (1) As of March 31, 2017, the Company had cash collateralizing a letter of credit for approximately $ 120,000 June 15, 2017

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2017
Inventory Disclosure [Abstract]
INVENTORIES	5. INVENTORIES Inventories consist of the following (all amounts in thousands): March 31, December 31, 2017 2016 Raw materials $ 4,668 $ 4,568 Work-in-process 1,945 2,267 Finished goods 1,612 1,549 $ 8,225 $ 8,384

CREDIT LINE AND NOTES PAYABLE

CREDIT LINE AND NOTES PAYABLE	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
CREDIT LINE AND NOTES PAYABLE	6. CREDIT LINE AND NOTES PAYABLE Monroe Refinancing On May 18, 2015, the Company entered into a credit agreement with Monroe Capital Management Advisors, LLC (the “Monroe Credit Agreement”), refinancing its existing senior and subordinated debt (see below). The Monroe Credit Agreement provides for a $ 25.0 5.0 18.0 2.0 The Monroe Credit Agreement has a term of five years and bears interest at a rate of the one-month LIBOR plus 9%. The Term A Loan requires quarterly repayments of approximately $ 113,000 225,000 June 30, 2016 March 31, 2017 450,000 June 30, 2017 March 31, 2020 11.3 Pursuant to the terms of the Monroe Credit Agreement, the Company must maintain: (i) a fixed charge coverage ratio of 1.25 to 1.00; (ii) a senior debt to EBITDA ratio initially of 4.50 to 1.00, decreasing to 1.50 to 1.00 over the term of the loans; and (iii) a twelve month trailing EBITDA, measured quarterly, with the amounts ranging from $4,750,000, increasing up to $7.0 million over the term of the loans. On August 3, 2015, the Company entered into a First Amendment (the “First Amendment”) to the Monroe Credit Agreement. Pursuant to the First Amendment, the Monroe Credit Agreement was amended to, among other things, reduce the aggregate amount of the Delayed Draw Loan under the Monroe Credit Agreement, which loan commitment was for purposes of funding a final payment due under the a legal settlement agreement, from $ 2.0 1.5 1.4 100,000 The Delayed Draw Loan, which was drawn on August 3, 2015, provides for quarterly amortization payments on the last day of each calendar quarter in an aggregate principal amount equal to 0.625% of the original principal amount of the Delayed Draw Loan, increasing to 1.25% on March 31, 2016, and increasing to 2.5% on March 31, 2017, In connection with the execution of the Monroe Credit Agreement, the Company issued 10 752,807.8 2.8 0.4 2.4 The proceeds from the Monroe Credit Agreement were allocated to the various instruments issued based on their relative fair value. Line of Credit The Monroe Line of Credit has a maximum borrowing capacity of $ 5.0 interest at a rate of the one-month LIBOR plus 9% May 18, 2020 $5.0 million and (ii) the sum of 85% of all eligible accounts receivable plus 60% of all eligible inventory 10 1.0 4.0 CTSAS has lines of credit, for borrowing against receivables, with a combined maximum borrowing capacity of € 750,000 801,120 Notes Payable March 31, December 31, 2017 2016 Monroe Term A Loan $ 13,817 $ 14,042 Delayed Draw Loan 1,229 1,266 Promissory Note Payable 323 430 Total 15,369 15,738 Less: Unamortized debt discount and unamortized debt issuance costs (2,708) (2,920) Less: Current portion of notes payable, including current portion of unamortized debt discount and current portion of unamortized debt issuance costs (1,288) (1,066) Notes payable, net of current portion $ 11,373 $ 11,752 Debt issuance costs are amortized to interest expense using the effective interest method over the life of the loan. The effective interest rate on the Term A Loan is approximately 19 22 Promissory Note Payable On November 19, 2013, the Company entered into a legal settlement agreement. The executed settlement agreement provided for the Company to make a series of payments to Antonio Colon in the amount of $ 215,000 1,075,000 2

PREFERRED STOCK

PREFERRED STOCK	3 Months Ended
	Mar. 31, 2017
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
PREFERRED STOCK	7. PREFERRED STOCK Series A Convertible Preferred Stock The Company is authorized to issue 1,000,000 On November 19, 2013, the Company entered into a Securities Purchase Agreement (the “Series A Purchase Agreement”) with US VC Partners, L.P. (the “Series A Investor”) for the purchase by the Investor of 123,077 4.0 32.50 0.001 Each share of Series A Preferred Stock may be converted at any time at the option of the holder into a number of shares of common stock initially equal to 50 0.65 0.13664587 Upon voluntary or involuntary liquidation, dissolution or winding up of the Company, each holder of Series A Preferred Stock is entitled to a liquidation preference of $ 32.50 Dividends on the Series A Preferred Stock accrue (payable in cash or in kind), whether or not declared by the Board and whether or not funds are available for the payment of dividends, at a rate of 12 Each share of Series A Preferred Stock will be entitled to a number of votes equal to the number of shares of common stock into which such share is convertible and shall be entitled to vote with holders of outstanding shares of common stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration. The requisite holders of the Series A Preferred Stock will have the right to cause the Company to redeem, out of funds legally available, all but not less than all of the then outstanding shares of Series A Preferred Stock, for a price per share equal to the Series A Liquidation Value of such shares, from and after the fifth anniversary of the closing date of the Series A Purchase Agreement. Additionally, the Company will have the right to redeem all of the outstanding shares of Series A Preferred Stock from and after the eighth anniversary of the closing date of the Series A Purchase Agreement at a redemption price equal to the Series A Liquidation Value. As a result of the redemption provisions, the Series A Preferred Stock has been classified outside of permanent equity. Series B Convertible Preferred Stock On July 30, 2014, the Company entered into a Securities Purchase Agreement (the “Series B and C Purchase Agreement”) with Cova Small Cap Holdings, LLC (“Cova”), Bayonet Capital Fund I, LLC (see Note 10), and another investor (each, an “Investor”) for the purchase by the Investors of an aggregate of 1,000 2.0 2,000 0.001 0.001 1.3 The shares of Series B Preferred Stock have the rights and preferences set forth in the Certificate of Designation of Series B Convertible Preferred Stock, which was amended on May 15, 2015 (the “Amended Series B Certificate of Designation”). Pursuant to the Amended Series B Certificate of Designation, each share of Series B Preferred Stock ranks senior to the Company’s common stock (the “Common Stock”) and the Company’s Series A Preferred Stock with respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company. Upon the Company’s liquidation, sale to or merger with another corporation or other “Change of Control” (as such term is defined in the Amended Series B Certificate of Designation), each share of Series B Preferred Stock would be entitled to a liquidation preference in an amount equal to the amount per share that would have been payable had all shares of Series B Preferred Stock been converted into Common Stock immediately prior to such event in accordance with the terms of the Amended Series B Certificate of Designation, excluding for purposes of such calculation the liquidation preference payable to the holders of Series A Preferred Stock. Holders of the Series B Preferred Stock are entitled to convert at any time all or any portion of the shares of Series B Preferred Stock into a number of shares of Common Stock initially equal to 35,713.147 shares of Common Stock per share of Series B Preferred Stock (the “Conversion Number”). The Conversion Number is subject to customary adjustments, including for dividends, stock splits and other reorganizations affecting the Common Stock. In addition, the Conversion Number is subject to anti-dilution protections, subject to certain exceptions, if the Company issues or sells shares of Common Stock or other equity securities for no consideration or for consideration that is based on an equity valuation of the Company of less than $ 2.0 (i) two-thirds of the Common Stock deemed Outstanding (as defined in the Amended Series A Certificate of Designation) immediately following such Trigger Issuance (excluding any Common Stock Deemed Outstanding as a result of the conversion of the Series B Preferred Stock) (ii) divided by 1,000. Series C Preferred Stock The shares of Series C Preferred Stock have the rights and preferences set forth in the Certificate of Designation of Series C Preferred Stock, which was amended on May 15, 2015 (the “Amended Series C Certificate of Designation”). Pursuant to the Amended Series C Certificate of Designation, each share of Series C Preferred Stock ranks senior to the Common Stock, the Series A Preferred Stock, the Series B Preferred Stock and the Series D Preferred Stock with respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company. Upon the Company’s liquidation, sale to or merger with another corporation or other “Change of Control” (as such term is defined in the Amended Series C Certificate of Designation), each share of Series C Preferred Stock would be entitled to a liquidation preference equal to the sum of: (1) $ 3,000 12 2,000 75 Series D Convertible Preferred Stock In connection with the execution of the Monroe Credit Agreement, the Company entered into a Subscription Agreement (the “Subscription Agreement”) with Monroe Capital Corporation, Monroe Capital Senior Secured Direct Loan Fund LP, Monroe Capital Senior Secured Direct Loan Fund (Unleveraged) LP and Monroe Capital Partners Fund II, LP. Pursuant to the Subscription Agreement, the Company issued 10 0.001 In the event of any voluntary or involuntary liquidation, the holders of the Series D Convertible Preferred Stock shall be entitled to be paid out of the assets of the Corporation available for distribution to its stockholders before any payment shall be made to the holders of junior securities. The Series C Preferred Stockholders would receive the Base Liquidation Value first, and not be entitled to the Excess Liquidation Value (as defined in the Amended Certificate of Designation of the Series C Preferred Stock) until the holders of the Series D Convertible Preferred Stock receive a pro rata Liquidation Value amount in cash. If at any time the Company redeems the outstanding shares of Series A Preferred Stock or Series C Preferred Stock, the holders of the Series D Preferred Stock would have the right to elect to cause the Company to redeem, out of funds legally available therefore, all but not less than all of the then outstanding shares of Series D Preferred Stock, for a price per share equal to the Liquidation Value for such shares; provided that, prior to the Company paying the full redemption price for all outstanding shares of Series D Preferred Stock, the Company would not be permitted to pay (i) any amounts in excess of the Series C Base Liquidation Value upon the redemption of shares of Series C Preferred Stock or (ii) any amounts upon the redemption of shares of Series A Preferred Stock. In the event of a voluntary or involuntary liquidation, each share of Series D Preferred Stock would be entitled to a liquidation preference in an amount equal to the amount per share that would have been payable had all shares of Series D Preferred Stock been converted into Common Stock immediately prior to such event in accordance with the terms of the Series D Certificate of Designation, excluding for purposes of such calculation the liquidation preference payable to the holders of Series A Preferred Stock and the holders of Series B Preferred Stock. The Series D Preferred Stock does not have any voting rights, except that the written consent of the holders of a majority of the then-outstanding Series D Preferred Stock shall be required for the Company to take certain actions, including the amendment of its certificate of incorporation or bylaws in a manner that adversely affects the relative rights, preferences, privileges or powers of holders of Series D Preferred Stock. As a result of the redemption provisions, the Series D Convertible Preferred Stock has been classified outside of permanent equity.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2017
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	8. STOCKHOLDERS’ EQUITY Common Stock The Company is authorized to issue 150,000,000 Common Stock Purchase Warrants Common stock purchase warrants accounted for within equity are recorded at their initial fair value and reported in stockholders’ equity as increases to additional paid-in capital. Warrants reported as equity, rather than liabilities (i) may not be net-cash settled, (ii) have contractual limits on the number of shares to be delivered in a net-share settlement and (iii) are supported by sufficient unissued common shares available to settle the outstanding warrants. Subsequent changes in fair value from the warrants’ initial fair value are not recognized as long as the warrants continue to merit classification as equity. As of March 31, 2017 and December 31, 2016, respectively, warrants to purchase 187,564 455,514 Pursuant to the terms of a letter agreement previously entered into between the Company and Dragonfly Capital Partners, LLC (“Dragonfly”) under which Dragonfly provided advisory services to the Company in connection with the Company’s debt financing, the Company paid $ 820,000 1,003,744 0.05 43,000 Number of Shares Exercisable Under Exercise Expiration Warrant Holder Warrant Price Date Patriot Capital II, L.P. (“Patriot”) 187,564 $ 0.01 November 19, 2023 Warrants to purchase the Company’s common stock were outstanding as follows as of December 31, 2016: Warrant Holder Number of Shares Exercisable Under Exercise Expiration Granite Creek Flex Cap I, L.P. (“Granite”) 267,950 $ 0.01 November 19, 2023 Patriot Capital II, L.P. (“Patriot”) 187,564 $ 0.01 November 19, 2023 Dragonfly Capital Partners, LLC 1,003,744 $ 0.05 May 18, 2020 March 31, December 31, Stock price of underlying equity $ 0.25 $ 0.16 Exercise price $ 0.01 $ 0.01 Expected term (years) 6.6 6.9 Risk-free interest rate 2.08 % 2.09 % Estimated dividend yield None None Volatility 180.6 % 178.91 % Granite and Patriot Warrants (see Note 13) Warrant liability at December 31, 2016 $ 72 Exercise of warrant (63) Change in fair value of warrants 38 Warrant liability at March 31, 2017 $ 47

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	9. INCOME TAXES During the three months ended March 31, 2017 and 2016, the Company incurred tax expense of approximately $95,000 and $36,000, respectively, on foreign income generated by the Company’s CTSAS subsidiary. The remaining income tax expense reflected for the three months ended March 31, 2017 and 2016, respectively, reflects tax expense on U.S. income generated. Due to management’s assessment that it is more likely than not that a portion of certain deferred tax assets may not be realized, the Company has a valuation allowance of approximately $11.8 million as of March 31, 2017 against its U.S. deferred tax asset, which was generated primarily as a result of foreign tax credits and net operating losses.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTION	10. RELATED PARTY TRANSACTIONS Financing Arrangements with Related Parties In December 2012, the Company entered into a $ 2,100,000 12 2.1 0.5 1.0 32.50 650 20 CSP leases property in Bound Brook, New Jersey, from Brook Industrial Park, LLC. on a month-to-month basis, at a monthly amount of approximately $ 30,000 Bayonet Capital Fund I, LLC, Brook Industrial Park, LLC and JFC are controlled by James Schleck. On July 30, 2014, 100 Other Related Party Transactions CSP sells product to Organic Dyes and Pigments, LLC (“Organic Dyes”). Michael Barry, a Board member of the Company, owns approximately 19 0.1 0.1

NET INCOME PER COMMON SHARE

NET INCOME PER COMMON SHARE	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
NET LOSS PER COMMON SHARE	11. NET INCOME PER COMMON SHARE Basic income per common share is computed by dividing net income available to common stockholders by the basic weighted average number of common shares outstanding. Diluted income per common share is computed by dividing net income available to common stockholders by the weighted average number of common shares and dilutive potential common share equivalents then outstanding. Potential common share equivalents consist of (i) shares issuable upon the exercise of warrants and options (using the “treasury stock” method), (ii) unvested restricted stock awards (using the “treasury stock” method) and (iii) shares issuable upon conversion of convertible notes and convertible preferred stock using the “if-converted” method. (in thousands, except shares and per share information) Three Months Ended March 31, 2017 2016 Numerator (in thousands): Net income $ 715 $ 479 Less: Series A convertible preferred stock dividends (172) (154) Less: Series C preferred stock dividends (79) (71) Net income available to common stockholders – basic $ 464 $ 254 Effect of dilutive securities: Add: Series A convertible preferred stock dividends 172 154 Add: Change in fair value of warrant liability for dilutive warrants expense 0 (13) Income available to common stockholders – diluted $ 636 $ 395 (in thousands, except shares and per share information) Three Months Ended March 31, 2017 2016 Denominator: Weighted average common shares outstanding – basic 22,084,684 21,400,244 Weighted average effect of dilutive common equivalent shares: Assumed conversion of Series A convertible preferred stock 43,583,989 38,723,815 Assumed conversion of Series B convertible preferred stock 35,713,147 35,713,147 Assumed conversion of Series D convertible preferred stock 7,528,078 7,528,078 Warrants 152,211 862,958 Options 6,380,427 9,152 Weighted average common shares outstanding – diluted 115,442,536 104,237,394 Income per common share: Basic $ 0.02 $ 0.01 Diluted $ 0.01 $ 0.00 Three Months Ended March 31, 2017 2016 Options 1,023,333 1,258,082 Warrants 187,564 0

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Legal From time to time and in the ordinary course of business, the company may be subject to various claims, charges, and litigation. At March 31, 2017, the company did not have any pending claims, charges or litigation that it expects would have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

FAIR VALUES OF ASSETS AND LIABI

FAIR VALUES OF ASSETS AND LIABILITIES	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
FAIR VALUES OF ASSETS AND LIABILITIES	13. FAIR VALUES OF ASSETS AND LIABILITIES Under U.S. GAAP, the Company is required to record certain financial assets and liabilities at fair value and may choose to record other financial assets and financial liabilities at fair value as well. Also under U.S. GAAP, the Company is required to record nonfinancial assets and liabilities at fair value due to events that may or may not recur in the future, such as an impairment event. When required to record such assets and liabilities at fair value, that fair value is estimated using an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. That fair value is determined based on significant inputs contained in a fair value hierarchy as follows: Level 1 Quoted prices for identical assets or liabilities in active markets to which the Company has access at the measurement date. Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 Unobservable inputs for the asset or liability. The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three general valuation techniques that may be used to measure fair value, as described below: Market Approach Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. Prices may be indicated by pricing guides, sale transactions, market trades, or other sources. Cost Approach Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost). Income Approach Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (includes present value techniques and option-pricing models). Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate. Assets and Liabilities Measured at Fair Value on a Recurring Basis Level 1 Quoted Prices in Active Level 2 Markets Significant Level 3 Assets/ for Other Significant (Liabilities) Identical Observable Unobservable At Fair Assets Inputs Inputs Value Warrants (see Note 8) (1) 0 0 (47) (47) $ 0 $ 0 $ (47) $ (47) (1) The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model. March 31, December 31, 2017 2016 Warrants liability: Balance at the beginning of period $ 72 $ 54 Exercise of Granite warrant (63) 0 Change in fair value of warrants 38 18 Balance at the end of period $ 47 $ 72 The Company has other financial instruments, such as cash, accounts receivable, due from related party, accounts payable, notes payable and a line of credit. The Company believes the carrying amounts of those assets and liabilities approximate their fair value since those carrying amounts have been estimated to approximate the exit price which would be received to sell these assets or pay to transfer these liabilities to a market participant. Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis During the three months ended March 31, 2017, none of the Company’s assets or liabilities were remeasured at fair value on a nonrecurring basis and no assets were identified as impaired as of March 31, 2017.

SUPPLEMENTAL DISCLOSURE OF CASH

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	3 Months Ended
	Mar. 31, 2017
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	14. SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash Paid for Interest and Income Taxes (all amounts in thousands) : Three Months Ended March 31 2017 2016 Interest $ 406 $ 505 Income taxes 125 98 Non-Cash Investing and Financing Activities (all amounts in thousands) : Three Months Ended March 31 2017 2016 Series A Convertible Preferred stock accrued dividend $ 172 $ 154 Series C Preferred stock accrued dividend 79 71

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	15. SUBSEQUENT EVENTS Pursuant to the terms of the Monroe Credit Agreement, the Company expects to make an excess cash payment of approximately $ 0.6

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Mar. 31, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	16. NEW ACCOUNTING PRONOUNCEMENTS The following are recent accounting pronouncements that have affected the Company’s consolidated financial statements or may affect the Company’s consolidated financial statements in the future. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10) In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation- Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) – Classification of Certain Cash Receipts and Cash Payments In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230) – Restricted Cash In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment

PREPAID EXPENSES AND OTHER CU23

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)	3 Months Ended
	Mar. 31, 2017
Prepaid Expense and Other Assets, Current [Abstract]
Schedule Of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consist of the following (all amounts in thousands): March 31, December 31, 2017 2016 Prepaid expenses $ 897 $ 617 Debt issuance costs 422 456 Restricted cash (1) 120 0 Other current assets 5 5 $ 1,444 $ 1,078 (1) As of March 31, 2017, the Company had cash collateralizing a letter of credit for approximately $ 120,000 June 15, 2017

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2017
Inventory Disclosure [Abstract]
INVENTORIES	Inventories consist of the following (all amounts in thousands): March 31, December 31, 2017 2016 Raw materials $ 4,668 $ 4,568 Work-in-process 1,945 2,267 Finished goods 1,612 1,549 $ 8,225 $ 8,384

CREDIT LINE AND NOTES PAYABLE (

CREDIT LINE AND NOTES PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Schedule of Debt	Outstanding notes payable consist of (all amounts in thousands): March 31, December 31, 2017 2016 Monroe Term A Loan $ 13,817 $ 14,042 Delayed Draw Loan 1,229 1,266 Promissory Note Payable 323 430 Total 15,369 15,738 Less: Unamortized debt discount and unamortized debt issuance costs (2,708) (2,920) Less: Current portion of notes payable, including current portion of unamortized debt discount and current portion of unamortized debt issuance costs (1,288) (1,066) Notes payable, net of current portion $ 11,373 $ 11,752

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	3 Months Ended
	Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Stockholders Equity Note, Warrants or Rights	Number of Shares Exercisable Under Exercise Expiration Warrant Holder Warrant Price Date Patriot Capital II, L.P. (“Patriot”) 187,564 $ 0.01 November 19, 2023 Warrants to purchase the Company’s common stock were outstanding as follows as of December 31, 2016: Warrant Holder Number of Shares Exercisable Under Exercise Expiration Granite Creek Flex Cap I, L.P. (“Granite”) 267,950 $ 0.01 November 19, 2023 Patriot Capital II, L.P. (“Patriot”) 187,564 $ 0.01 November 19, 2023 Dragonfly Capital Partners, LLC 1,003,744 $ 0.05 May 18, 2020
Schedule Of Change In The Fair Value Of The Warrants Liability	Granite and Patriot Warrants (see Note 13) Warrant liability at December 31, 2016 $ 72 Exercise of warrant (63) Change in fair value of warrants 38 Warrant liability at March 31, 2017 $ 47
Patriot Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair value as of March 31, 2017 and December 31, 2016 of the Company’s liability warrants is estimated using the Black-Scholes pricing model with the following inputs: March 31, December 31, Stock price of underlying equity $ 0.25 $ 0.16 Exercise price $ 0.01 $ 0.01 Expected term (years) 6.6 6.9 Risk-free interest rate 2.08 % 2.09 % Estimated dividend yield None None Volatility 180.6 % 178.91 %

NET INCOME PER COMMON SHARE (Ta

NET INCOME PER COMMON SHARE (Tables)	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
Net Income Per Common Share	(in thousands, except shares and per share information) Three Months Ended March 31, 2017 2016 Numerator (in thousands): Net income $ 715 $ 479 Less: Series A convertible preferred stock dividends (172) (154) Less: Series C preferred stock dividends (79) (71) Net income available to common stockholders – basic $ 464 $ 254 Effect of dilutive securities: Add: Series A convertible preferred stock dividends 172 154 Add: Change in fair value of warrant liability for dilutive warrants expense 0 (13) Income available to common stockholders – diluted $ 636 $ 395 (in thousands, except shares and per share information) Three Months Ended March 31, 2017 2016 Denominator: Weighted average common shares outstanding – basic 22,084,684 21,400,244 Weighted average effect of dilutive common equivalent shares: Assumed conversion of Series A convertible preferred stock 43,583,989 38,723,815 Assumed conversion of Series B convertible preferred stock 35,713,147 35,713,147 Assumed conversion of Series D convertible preferred stock 7,528,078 7,528,078 Warrants 152,211 862,958 Options 6,380,427 9,152 Weighted average common shares outstanding – diluted 115,442,536 104,237,394 Income per common share: Basic $ 0.02 $ 0.01 Diluted $ 0.01 $ 0.00
Common Shares Issuable upon Vesting or Exercise of Convertible Securities	The following potentially dilutive common share equivalents were excluded from the calculation of diluted earnings per common share because their effect was antidilutive for each of the periods presented: Three Months Ended March 31, 2017 2016 Options 1,023,333 1,258,082 Warrants 187,564 0

FAIR VALUES OF ASSETS AND LIA28

FAIR VALUES OF ASSETS AND LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	Assets and liabilities itemized below were measured at fair value on a recurring basis at March 31, 2017 (all amounts in thousands): Level 1 Quoted Prices in Active Level 2 Markets Significant Level 3 Assets/ for Other Significant (Liabilities) Identical Observable Unobservable At Fair Assets Inputs Inputs Value Warrants (see Note 8) (1) 0 0 (47) (47) $ 0 $ 0 $ (47) $ (47) (1) The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.
Reconciliation of Contingent Consideration Liability Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs	The tables below presents reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (all amounts in thousands): March 31, December 31, 2017 2016 Warrants liability: Balance at the beginning of period $ 72 $ 54 Exercise of Granite warrant (63) 0 Change in fair value of warrants 38 18 Balance at the end of period $ 47 $ 72

SUPPLEMENTAL DISCLOSURE OF CA29

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2017
Supplemental Cash Flow Elements [Abstract]
Cash Paid for Interest and Income Taxes	Cash Paid for Interest and Income Taxes (all amounts in thousands) : Three Months Ended March 31 2017 2016 Interest $ 406 $ 505 Income taxes 125 98
Non-Cash Investing and Financing Activities	Non-Cash Investing and Financing Activities (all amounts in thousands) : Three Months Ended March 31 2017 2016 Series A Convertible Preferred stock accrued dividend $ 172 $ 154 Series C Preferred stock accrued dividend 79 71

PREPAID EXPENSES AND OTHER CU30

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule Of Prepaid Expenses And Other Current Assets) (Detail) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Prepaid expenses		$ 897	$ 617
Debt issuance costs		422	456
Restricted cash	[1]	120	0
Other current assets		5	5
Prepaid expenses and other current assets total		$ 1,444	$ 1,078
[1]	As of March 31, 2017, the Company had cash collateralizing a letter of credit for approximately $120,000 which was used to facilitate purchases of raw materials from overseas vendors. This letter of credit will mature on June 15, 2017 and was included in “Prepaid expenses and other current assets” in the Company’s Condensed Consolidated Balance Sheet as of March 31, 2017.

PREPAID EXPENSES AND OTHER CU31

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Additional Information) (Detail)	3 Months Ended
	Mar. 31, 2017USD ($)
Prepaid Expenses And Other Current Assets [Line Items]
Letters Of Credit Carrying Value	$ 120,000
Letters Of Credit Expiration Date	Jun. 15, 2017

INVENTORIES (Schedule Of Invent

INVENTORIES (Schedule Of Inventories) (Detail) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Schedule of Inventory [Line Items]
Raw materials	$ 4,668	$ 4,568
Work-in-process	1,945	2,267
Finished goods	1,612	1,549
Inventory, Net	$ 8,225	$ 8,384

CREDIT LINE AND NOTES PAYABLE33

CREDIT LINE AND NOTES PAYABLE (Outstanding Notes Payable) (Detail) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Promissory Note Payable	$ 323	$ 430
Total	15,369	15,738
Less: Unamortized debt discount and unamortized debt issuance costs	(2,708)	(2,920)
Less: Current portion of notes payable, including current portion of unamortized debt discount and current portion of unamortized debt issuance costs	(1,288)	(1,066)
Notes payable, net of current portion	11,373	11,752
Monroe Term A Loan [Member]
Bank Loans	13,817	14,042
Delayed Draw Loan [Member]
Bank Loans	$ 1,229	$ 1,266

CREDIT LINE AND NOTES PAYABLE34

CREDIT LINE AND NOTES PAYABLE (Additional Information) (Detail)	Aug. 03, 2015USD ($)	May 18, 2015USD ($)	Nov. 19, 2013USD ($)	Mar. 31, 2017USD ($)shares	Mar. 31, 2017EUR (€)shares	Dec. 31, 2016USD ($)shares
Notes Payable [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity				$ 801,120	€ 750,000
Line of Credit, Current				1,000,000		$ 0
Term A Loan And Delayed Draw Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Unamortized Discount				$ 2,400,000
Delayed Draw Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				22.00%	22.00%
Series D Convertible Preferred Stock [Member]
Notes Payable [Line Items]
Preferred Stock Shares Issued | shares				10	10	10
Long-term Debt, Fair Value				$ 2,800,000
Debt Instrument, Unamortized Discount				$ 400,000
Conversion of Stock, Shares Converted | shares				752,807.8
Monroe Credit Agreement [Member]
Notes Payable [Line Items]
Debt Instrument, Maturity Date		Jun. 30, 2017
Debt Instrument, Periodic Payment	$ 1,400,000	$ 11,300,000
Debt Instrument, Face Amount		$ 25,000,000
Line of Credit Facility, Interest Rate Description		interest at a rate of the one-month LIBOR plus 9%
Line of Credit Facility, Covenant Terms				a fixed charge coverage ratio of 1.25 to 1.00; (ii) a senior debt to EBITDA ratio initially of 4.50 to 1.00, decreasing to 1.50 to 1.00 over the term of the loans; and (iii) a twelve month trailing EBITDA, measured quarterly, with the amounts ranging from $4,750,000, increasing up to $7.0 million over the term of the loans.
Line of Credit Facility, Frequency of Payment and Payment Terms				quarterly amortization payments on the last day of each calendar quarter in an aggregate principal amount equal to 0.625% of the original principal amount of the Delayed Draw Loan, increasing to 1.25% on March 31, 2016, and increasing to 2.5% on March 31, 2017,
Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid	1,500,000
Debt Issuances Costs	100,000
Debt Instrument, Annual Principal Payment	$ 2,000,000
Monroe Credit Agreement [Member] | Series D Preferred Stock [Member]
Notes Payable [Line Items]
Preferred Stock Shares Issued | shares				10	10
Monroe Credit Agreement [Member] | Quarterly Repayments Beginning on June 30, 2015 through March 31, 2016 [Member]
Notes Payable [Line Items]
Debt Instrument, Periodic Payment		$ 113,000
Monroe Credit Agreement [Member] | Quarterly Repayments Beginning On June 30, 2016 Through March 31, 2017 [Member]
Notes Payable [Line Items]
Debt Instrument, Periodic Payment		225,000
Monroe Credit Agreement [Member] | Quarterly Repayments Of Beginning on June 30, 2017 through March 31, 2020 [Member]
Notes Payable [Line Items]
Debt Instrument, Periodic Payment		450,000
Monroe Credit Agreement [Member] | Revolving Credit Facility [Member]
Notes Payable [Line Items]
Debt Instrument, Face Amount		5,000,000
Monroe Credit Agreement [Member] | Secured Debt [Member]
Notes Payable [Line Items]
Debt Instrument, Face Amount		18,000,000
Monroe Credit Agreement [Member] | Legal Reserve Delayed Draw Term Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Face Amount		$ 2,000,000
TD Bank [Member]
Notes Payable [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity				$ 5,000,000
Line of Credit Facility, Interest Rate During Period				10.00%
Line of Credit Facility, Remaining Borrowing Capacity				$ 4,000,000
TD Bank [Member] | Monroe Credit Agreement [Member]
Notes Payable [Line Items]
Line of Credit, Current				$ 1,000,000
Line of Credit Facility, Covenant Terms				$5.0 million and (ii) the sum of 85% of all eligible accounts receivable plus 60% of all eligible inventory
Promissory Notes Payable [Member]
Notes Payable [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Debt Instrument, Periodic Payment			$ 215,000
Debt Instrument, Face Amount			$ 1,075,000
Before Amendment [Member] | Monroe Credit Agreement [Member]
Notes Payable [Line Items]
Debt Instrument, Maturity Date		Mar. 31, 2020
Maximum [Member] | Monroe Credit Agreement [Member]
Notes Payable [Line Items]
Debt Instrument, Maturity Date				May 18, 2020
Subordinated Term Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Maturity Date		Mar. 31, 2017
Term Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				0.00%	0.00%
Debt Instrument, Maturity Date		Jun. 30, 2016

PREFERRED STOCK (Additional Inf

PREFERRED STOCK (Additional Information) (Detail) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended		3 Months Ended
	Jul. 30, 2014	Nov. 19, 2013	Mar. 31, 2017	Dec. 31, 2016
Series A Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Liquidation Preference Per Share			$ 32.50
Convertible Preferred Stock, Shares Issued upon Conversion			50
Convertible Preferred Stock Conversion Price			$ 0.65
Conversion Price	$ 0.13664587
Series A Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001
Preferred Stock, Dividend Rate, Percentage			12.00%
Preferred Stock Shares Issued			123,097	123,097
Series A Convertible Preferred Stock [Member] | Minimum [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Liquidation Preference Per Share			$ 3,000
Series C Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001
Preferred Stock, Dividend Rate, Percentage			12.00%
Preferred Stock Liquidation Preference Description			each share of Series C Preferred Stock would be entitled to a liquidation preference equal to the sum of: (1) $3,000 per share (the Base Liquidation Value) and the (2) the amount, if any, by which the Base Value exceeds 150% of the purchase price (the Excess Liquidation Value), plus any accrued but unpaid dividends, in each case subject to customary adjustments as set forth in the Amended Series C Certificate of Designation.
Preferred Stock Dividend Payable Percentage Of Shares			75.00%
Accrued Dividends Payable In Cash Or In Kind Per Share			$ 2,000
Preferred Stock Shares Issued			1,000	1,000
Series B convertible preferred stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001
Conversion of Stock, Shares Converted	35,713.147
Preferred Stock Shares Issued			1,000	1,000
Series D Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001
Conversion of Stock, Shares Converted			752,807.8
Preferred Stock Shares Issued			10	10
Purchase Agreement [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Value, Other	$ 2
Convertible Preferred Stock, Terms of Conversion	(i) two-thirds of the Common Stock deemed Outstanding (as defined in the Amended Series A Certificate of Designation) immediately following such Trigger Issuance (excluding any Common Stock Deemed Outstanding as a result of the conversion of the Series B Preferred Stock) (ii) divided by 1,000.
Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock Par Or Stated Value Per Share		$ 0.001
Series A Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Shares, Other		123,077
Stock Issued During Period, Value, Other		$ 4
Sale of Stock, Price Per Share		$ 32.50
Series B and C Purchase Agreement [Member] | Series B convertible preferred stock [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Shares, Other	1,000
Stock Issued During Period, Value, Other	$ 2
Sale of Stock, Price Per Share	$ 2,000
Preferred Stock Par Or Stated Value Per Share	$ 0.001
Net Proceeds from Sale of Preferred Units Used to Pay Contingent Legal Obligation	$ 1.3
Series B and C Purchase Agreement [Member] | Series C Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock Par Or Stated Value Per Share	$ 0.001

STOCKHOLDERS' EQUITY (Warrants

STOCKHOLDERS' EQUITY (Warrants To Purchase Common Stock Outstanding) (Detail) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	May 18, 2015
Class of Warrant or Right [Line Items]
Number of Shares Exercisable Under Warrant	187,564	455,514
Granite Creek FlexCap I, L.P [Member]
Class of Warrant or Right [Line Items]
Number of Shares Exercisable Under Warrant		267,950
Exercise Price		$ 0.01
Expiration Date		Nov. 19, 2023
Patriot Capital II, L.P [Member]
Class of Warrant or Right [Line Items]
Number of Shares Exercisable Under Warrant	187,564	187,564
Exercise Price	$ 0.01	$ 0.01
Expiration Date	Nov. 19, 2023	Nov. 19, 2023
Dragonfly Capital Partners, LLC [Member]
Class of Warrant or Right [Line Items]
Number of Shares Exercisable Under Warrant		1,003,744	1,003,744
Exercise Price		$ 0.05	$ 0.05
Expiration Date		May 18, 2020

STOCKHOLDERS' EQUITY (Patriot W

STOCKHOLDERS' EQUITY (Patriot Warrants is estimated using the Black-Scholes pricing model) (Detail) - Patriot Warrants [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price of underlying equity	$ 0.25	$ 0.16
Exercise price	$ 0.01	$ 0.01
Expected term (years)	6 years 7 months 6 days	6 years 10 months 24 days
Risk-free interest rate	2.08%	2.09%
Estimated dividend yield	0.00%	0.00%
Volatility	180.60%	178.91%

STOCKHOLDERS' EQUITY (Change In

STOCKHOLDERS' EQUITY (Change In The Fair Value Of The Warrants Liability) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Class of Warrant or Right [Line Items]
Change in fair value of warrants	$ 38	$ (13)
Granite and Patriot Warrants [Member]
Class of Warrant or Right [Line Items]
Warrant liability at December 31, 2016	72
Exercise of warrant	(63)
Change in fair value of warrants	38
Warrant liability at March 31, 2017	$ 47

STOCKHOLDERS' EQUITY (Additiona

STOCKHOLDERS' EQUITY (Additional Information) (Detail) - USD ($)	1 Months Ended	3 Months Ended
	May 18, 2015	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Stockholders Equity Additional Information [Line Items]
Common stock, shares authorized		150,000,000		150,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		187,564		455,514
Fair Value Adjustment of Warrants		$ 38,000	$ (13,000)
Dragonfly Capital Partners, LLC [Member]
Stockholders Equity Additional Information [Line Items]
Debt Issuances Costs	$ 820,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1,003,744			1,003,744
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.05			$ 0.05
Monroe Warrant [Member] | Dragonfly Warrant [Member]
Stockholders Equity Additional Information [Line Items]
Fair Value Adjustment of Warrants	$ 43,000

INCOME TAXES (Additional Inform

INCOME TAXES (Additional Information) (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Current Foreign Tax Expense (Benefit)	$ 95,000	$ 36,000
Deferred Tax Assets, Valuation Allowance, Noncurrent	$ 11,800,000

RELATED PARTY TRANSACTIONS (Add

RELATED PARTY TRANSACTIONS (Additional Information) (Detail) - USD ($)	1 Months Ended		3 Months Ended
	Aug. 31, 2016	May 18, 2015	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Jul. 30, 2014	Nov. 19, 2013	Dec. 31, 2012
Jfc [Member]
Related Party Transaction [Line Items]
Unsecured Debt								$ 2,100,000
Amended JFC Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Stated Percentage							12.00%
Debt Instrument, Convertible, Conversion Price							$ 32.50
Convertible Debt		$ 1,000,000
Repayments of Related Party Debt		2,100,000
Repayments Of Related Party Debt, Accrued interest		500,000
James Schleck [Member] | Series A Preferred Stock [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Amount		$ 650
Debt Conversion, Converted Instrument, Shares Issued		20
Cyalume Specialty Products Inc [Member]
Related Party Transaction [Line Items]
Monthly Lease Payments Due To Related Parties	$ 30,000
Revenue from Related Parties			$ 100,000	$ 100,000
Due from Related Parties, Current					$ 12,000,000
Cyalume Specialty Products Inc [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Due from Related Parties, Current			$ 100,000		$ 12,000,000
Organic Dyes [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent			19.00%
Bayonet Capital Fund I Llc [Member]
Related Party Transaction [Line Items]
Preferred Units, Issued						100

NET INCOME PER COMMON SHARE (Ne

NET INCOME PER COMMON SHARE (Net Income Per Common Share) (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Numerator
Net income	$ 715	$ 479
Net income available to common stockholders - basic	464	254
Effect of dilutive securities:
Add: Series A convertible preferred stock dividends	172	154
Add: Change in fair value of warrant liability for dilutive warrants expense	0	(13)
Income available to common stockholders - diluted	$ 636	$ 395
Denominator:
Weighted average common shares outstanding - basic	22,084,684	21,400,244
Weighted average effect of dilutive common equivalent shares:
Warrants	152,211	862,958
Options	6,380,427	9,152
Weighted average common shares outstanding - diluted	115,442,536	104,237,394
Income per common share:
Basic	$ 0.02	$ 0.01
Diluted	$ 0.01	$ 0
Series B convertible preferred stock
Numerator
Net income	$ 0
Weighted average effect of dilutive common equivalent shares:
Assumed conversion of convertible preferred stock	35,713,147	35,713,147
Series D convertible preferred stock [Member]
Weighted average effect of dilutive common equivalent shares:
Assumed conversion of convertible preferred stock	7,528,078	7,528,078
Series A Convertible Preferred Stock [Member]
Numerator
Preferred stock dividends	$ (172)	$ (154)
Series C preferred stock dividends [Member]
Numerator
Preferred stock dividends	(79)	$ (71)
Series A Preferred Stock [Member]
Numerator
Net income	$ 0
Weighted average effect of dilutive common equivalent shares:
Assumed conversion of convertible preferred stock	43,583,989	38,723,815

NET INCOME PER COMMON SHARE (Di

NET INCOME PER COMMON SHARE (Dilutive Common Share Equivalents Were Excluded From The Calculation Of Diluted Net Income Per Common Share) (Detail) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	1,023,333	1,258,082
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	187,564	0

FAIR VALUES OF ASSETS AND LIA44

FAIR VALUES OF ASSETS AND LIABILITIES (Assets And Liabilities Measured At Fair Value On Recurring Basis) (Detail) $ in Thousands	Mar. 31, 2017USD ($)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	$ (47)
Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	(47)	[1]
Level 1 Quoted Prices in Active Markets for Identical Assets [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0
Level 1 Quoted Prices in Active Markets for Identical Assets [Member] | Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]
Level 2 Significant Other Observable Inputs [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0
Level 2 Significant Other Observable Inputs [Member] | Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]
Level 3 Significant Unobservable Inputs [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	(47)
Level 3 Significant Unobservable Inputs [Member] | Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	$ (47)	[1]
[1]	The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.

FAIR VALUES OF ASSETS AND LIA45

FAIR VALUES OF ASSETS AND LIABILITIES (Consideration Liability Measured at Fair Value on Recurring Basis) (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Balance at the end of period	$ 47
Warrants Liability [Member]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Balance at the beginning of period	72	$ 54
Change in fair value of warrants	38	18
Balance at the end of period	47	72
Warrants Liability [Member] | Partnership Interest [Member]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Exercise of Granite warrant	$ (63)	$ 0

SUPPLEMENTAL DISCLOSURE OF CA46

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Cash Paid for Interest and Income Taxes) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Interest	$ 406	$ 505
Income taxes	$ 125	$ 98

SUPPLEMENTAL DISCLOSURE OF CA47

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Non-Cash Investing and Financing Activities) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Series A Convertible Preferred stock accrued dividend [Member]
Non-Cash Investing And Financing Activities [Line Items]
Preferred stock dividends	$ 172	$ 154
Series C Preferred stock accrued dividend [Member]
Non-Cash Investing And Financing Activities [Line Items]
Preferred stock dividends	$ 79	$ 71

SUBSEQUENT EVENTS (Additional I

SUBSEQUENT EVENTS (Additional Information) (Detail) $ in Millions	May 17, 2017USD ($)
Credit Agrement [Member] | Subsequent Event [Member]
Debt Instrument, Annual Principal Payment	$ 0.6